Metabolomics: Technologies and Global Markets

02 Dec, 2015, 15:10 ET from Reportlinker

NEW YORK, Dec. 2, 2015 /PRNewswire/ -- This BCC report details the recent key technical advances in metabolomic methods, analytical equipment, assay kits, bioinformatics solutions and clinical biomarker applications. Includes forecast through 2020.

Use this report to:

Assess the growth potential of the metabolomic market over the five-year period from 2015 to 2020.
Understand current market adoption in terms of both scope and maturity.
Learn about technology developments including the latest trends and other influential factors such as screening strategies for pharmaceuticals.
Receive information about major applications being developed with regard to the industry, academic researchers and their commercialization offices, and government agencies.

Highlights

The global metabolomic market totaled $5.9 billion in 2014, and should total $6.8 billion in 2015 and $12.5 billion by 2020, registering a compound annual growth rate (CAGR) of 13.0%.
The clinical biomarker metabolomic applications market should total $4.1 billion in 2015 and $7.9 billion by 2020, increasing at a five-year CAGR of 13.8% through 2020.
The metabolomic assay applications market should grow from $1.6 billion in 2015 to $3.1 billion by 2020, with a CAGR of 14.4%.

STUDY GOALS AND OBJECTIVES

BCC Research's goal in conducting this study was to update the status of the metabolomic market and assess its growth potential over the five-year period from 2015 to 2020. Particularly focus was placed on understanding the current market adoption and analyzing drivers for increasing this in terms of both scope (i.e., more applications) and maturity in terms of user adoption, collaboration with regulators and the emergence of standards.

In addition, BCC Research was interested in understanding the impact of these methods on different research sectors, specifically cancer, toxicology and safety testing; as well as the clinical application of biomarkers in cancer, cardiology, and liver and metabolic disease.

REASONS FOR DOING THE STUDY

Metabolomics is a fairly new field relative to genomics and proteomics, which are more mature, but it promises much needed breakthroughs by virtue of being more descriptive of the actual phenotype or working conditions of the human body. Whereas genomics describes the body's code and proteomics the application of that code into
the proteins that do the work, metabolomics describes and measures the resultant interaction of an individual's unique body with those proteins and with the environment.
This report details the recent key technical advances in metabolomic methods, analytical equipment, assay kits, bioinformatics solutions and clinical biomarker applications.

SCOPE OF REPORT

The scope of the report encompasses the major metabolomic technology types that have been used, as well as the major applications being developed by industry, academic researchers and their commercialization offices, and government agencies. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed. Other influential factors such as screening strategies for pharmaceuticals have also been included.




Read the full report: http://www.reportlinker.com/p01105927-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com